Aurenar
St. Louis, United States · $5.7M raised
- Headquarters
- St. Louis
- Business Model
- B2B
- Website
- aurenar.com
- Total Funding
- $5.7M
- Last Round
- $5.7M SeedJul 2026
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Aurenar is a company developing a non-invasive, single-use neuromodulation platform to reduce life-threatening complications in ICU patients. The company's transauricular vagus nerve stimulation (taVNS) device targets the body's inflammatory response to improve outcomes, lower total cost of care, and transform critical care management. Beginning with the impacts of stroke, Aurenar's platform is positioned to expand to address multiple high-acuity indications. Aurenar is headquartered in St. Louis, Missouri.
Summary
Aurenar is a Healthcare company based in St. Louis, United States. It has raised $5.7M in total across 1 round, most recently a $5.7M Seed round in Jul 2026. Investors include Go Red for Women Venture Fund.
Funding History
Jul 2026
Investors
Similar Companies
S4 Medical develops FDA-cleared devices that help physicians protect the esophagus during cathete...
Neko Health delivers preventive health scans that combine skin, heart, blood, and body measuremen...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
China's leading blood products manufacturer
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/aurenar"><img src="https://indexed.vc/api/badge/company/aurenar" alt="Aurenar on Indexed.vc" width="260" height="76" /></a>